Ligand Pharmaceuticals | LGND - Interest Income


Ligand Pharmaceuticals reported $1.62M in Interest Income for its fiscal quarter ending in June of 2025.





Interest Income Change Date
Arrowhead Research USD 9.05M 1.97M Sep/2025
Baxter International USD 14M 3M Jun/2025
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 73M 21M Jun/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Glaxosmithkline GBP 26M 24M Sep/2025
Insmed USD 765K 55K Sep/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Ligand Pharmaceuticals USD 1.62M 150K Jun/2025
MacroGenics USD 1.53M 114K Sep/2025
Merck USD 96M 27M Sep/2025
Pacira USD 5.01M 1.89M Jun/2025
Pfizer USD 0.62 156M Sep/2025
Veracyte USD 2.94M 175K Jun/2025